In addition, CM from IL1β-treated fibroblasts induces the overexpression of Cyclin D1 and cMyc, which might help explain how IL1β-soluble targets influence the cell-cycle progression and chemoresistance observed in tumor cells, when treated with L-OHP (Figure 4E). Here, IL1B is linked to neoplasm.